| INTRODUCTION
Food allergy is estimated to affect 6%-7% of children and 1%-2% of adults and may be increasing in prevalence. 1 Current management is based on avoidance of allergenic foods and prompt administration of treatment for allergic reactions. 2 Due to its unpredictable and potentially life-threatening nature, food allergy can provoke feelings of anxiety and stress for both sufferers and their caregivers. The dietary and social restrictions which accompany food allergy may result in children with food allergy and their parents feeling socially isolated. 3 Previous studies have suggested that children with food allergy and their mothers suffer increased anxiety and stress compared with other groups. [4] [5] [6] We recently found that community healthcare professionals significantly overestimate the risk of fatal anaphylaxis for children with food allergy, which may contribute to feelings of anxiety. 7 Allergic comorbidities such as asthma are often present in those with food allergy, and these can also be associated with anxiety in affected children and their caregivers. 8, 9 While oral and epicutaneous immunotherapy show promise as treatments to reduce immunologic sensitivity in people with food allergy, there is a need for treatments which effectively address the psychological and emotional burden of the disease. We recently developed a brief cognitive behavioural therapy (CBT) intervention, which includes an element of risk communication, for mothers of children with food allergy. 10 The possibility that a single-session CBT intervention may reduce anxiety is supported by a recent meta-analysis of single-session interventions for young people with mental health problems, although long-term effects are unclear. 11 In this manuscript, we report outcomes of the first prospective randomized controlled trial of a brief CBT intervention in mothers of children with food allergy, designed to evaluate whether it can influence maternal state anxiety.
2 | ME TH ODS
| Study design
We conducted a two-by-two factorial randomized controlled trial, on the effect of a psychological intervention on measures of maternal anxiety at 6 weeks (primary outcome) and 1 year after treatment, in mothers of children with food allergy (ISRCTN12504076). We simultaneously evaluated the effect of adrenaline auto-injector (AAI) device design on participants' ability to administer adrenaline in a simulated anaphylaxis scenario, and those results have been reported separately. 12 There was no interaction between the AAI training intervention and the CBT intervention for the study outcomes, and no effect of AAI treatment arm on these study outcomes.
| Participants
Mothers of children aged 0-18, diagnosed with food allergy by a paediatric allergist, who were deemed to need an AAI for the first time as part of their food allergy management, were eligible for inclusion. Exclusion criteria were inability to converse fluently in English or with a translator, child weight under 7.5 kg (a contraindication to AAI prescription), prior training in the use of an AAI device and significant psychiatric problems such as current treatment for psychosis that might be a contraindication to CBT.
| Study setting
Participants were recruited from a large specialist paediatric allergy centre in an urban setting in London, UK, between March 2011 and December 2012. Researchers invited eligible mothers to take part in the study, and written informed consent was obtained prior to participation in any study procedures. The study was approved by the West London Research Ethics Committee (10/H0711/76).
| Randomization, treatment allocation and masking
Treatment was allocated using a computer-generated randomization list in blocks of four, stratified by maternal State Trait Anxiety Inventory (STAI) score, generated by a statistician independent of the study team (Imperial College London Statistical Advisory Service).
The randomization list was held by a clinical trials pharmacist-researchers notified the pharmacist after enrolling a participant in the trial, and the pharmacist allocated treatment based on the randomization list. It was not possible to blind clinicians, participants or outcome assessors to treatment allocation in this trial. The primary outcome measure was a patient reported measure, state anxiety on the STAI (STAI-S), which has been used extensively in similar settings. Due to the possibility of ascertainment bias in an unblinded trial, we also evaluated objective measures of stress response using salivary samples, which were analysed by laboratory staff blind to treatment allocation.
| Intervention
Participants were randomized to receive either a single session of CBT, with reinforcement of CBT at a phone call 2 weeks later and a visit 6 weeks later, or no intervention. The CBT intervention was modified from existing single sessions used to treat fears and phobias. 13 The CBT intervention consisted of psychoeducation, including both the risk of living with high anxiety and the risk of fatal anaphylaxis for a child with food allergy, a cognitive component (coping thoughts) and a behavioural component (relaxation technique). The initial intervention was designed to be delivered within 45 minutes, and the reinforcement at 2 weeks and 6 weeks within 15 minutes. These estimates were based on our previous work. 14, 15 No specific information was given about risk of non-fatal anaphylaxis or allcause fatality. The control group received standard care with no CBT intervention. The development of the CBT intervention is described elsewhere, and the Manual for therapists is available in the Supplementary Material. 10 Briefly, therapists were trained over 3 half-day taught sessions, and provided with a training video and manual. They received weekly 2-hour supervision sessions for 4 months and then fortnightly 2-hour supervision sessions for 8 months. Supervision was structured to build skills and to model guided discovery for therapists. The supervisor was a Consultant Child Psychiatrist with a postgraduate diploma in CBT, and 10-year experience of delivering and teaching CBT. Therapists had no prior experience or training in CBT. One therapist was a paediatrician in training (UT), two were registered nurses (KP, HH), and one was a newly qualified psychologist (CP). The quality of delivered CBT was assessed using audiotapes CBT sessions as previously described. 10 In brief, BV used the Revised Cognitive Therapy Scale (CTS-R) to rate audiotapes, and a sample was rated by an independent assessor as a reliability check.
| Outcome measures
Participants were assessed at enrolment, 6 weeks after enrolment, and at 12 months. These time-points were chosen for practical reasons, because they sometimes coincided with clinical assessments for the study participants. and maternal change in salivary cortisol and alpha amylase levels following a simulated anaphylaxis scenario, at 12 months. Maternal risk perception was assessed using a Risk Ladder, developed using data from public databases and previous systematic reviews undertaken by our group. 14, 15 The Risk Ladder and comparator risks used are shown in Figs S2-S4. Full details of the outcome assessment methods are described in Appendix S1.
| Sample size
Prior work showed that mothers of children with food allergy have and "perceived stress" (mean 25.1, SD 6.7; control mean 19.6, SD 7.5) scores compared with a control population. 4 Randomizing 86 participants to intervention and 86 to standard care gives 80%
power at 5% two-sided significance to detect a difference in STAI-S from 39.0 to 34.4 with SD 10. This number of participants gives the same power to detect a difference in PSS of 25.1 vs 21.9 with SD 7.
We aimed to recruit 200 participants in order to allow for loss to follow-up. We did not evaluate for a minimal clinically important difference in STAI-S, as a minimal clinically important difference has not been established for mothers of children with food allergy or other chronic health conditions.
| Statistical methods
For binary comparisons, we used chi-squared test or Fisher's exact test; for continuous data, we used independent-group t tests with effect sizes computed as Cohen's d. 16 Where one or more data distributions deviated markedly from normal (ie skewness and/or kurtosis value(s) >1), bootstrapping (bias-corrected and accelerated; based on 2000 bootstrap samples) was employed to estimate 95% confidence intervals (CI) around mean difference. Within-group changes were assessed using paired-sample t tests with bootstrapping applied where distributions deviated markedly from normal. In the case of salivary markers (cortisol, amylase), where distributions of values were severely kurtotic and/or (positively) skewed at time-points, values were transformed using Box-Cox methods 17 to better approximate a normal distribution, and then, t tests and (for adjusted analyses) analysis of covariance were used. All primary analyses used group assignment as randomized, whether or not treatment was received, and were on an available case basis without imputation for missing outcome data. One planned subgroup analysis and two post hoc subgroup analyses were undertaken to evaluate the effect of the intervention in specific groups-the planned analysis was for participants with moderate-to-high anxiety at baseline, defined as STAI-S≥35. Post hoc analyses were for participants who received "good quality CBT", and for participants with accurate fatal anaphylaxis risk estimates postintervention. "Good quality CBT" was defined as a mean item score ≥3 on the CTS-R for those participants with a recorded therapy session-46 sessions were recorded, of which 31 (67%) had a CTS-R score ≥3; effective risk information was defined as an estimated "risk of fatal anaphylaxis" VAS at 6 weeks within 1 log of the true fatal anaphylaxis risk for their child-33 of 91 (34%) participants in the intervention group who completed the VAS at 6 weeks met this criterion. To control for the possibility of falsepositives because of multiple outcome testing, the false discovery rate approach was applied to each set of comparisons concerning participant-reported outcomes other than the primary outcome, with control set to 5%. 18 All statistical analyses used SPSS v22.0 (IBM, Armonk, NY, USA).
| RESULTS
We | 1311 study participants at enrolment are shown in Table 1 . Fifty-three percent of participants had a university degree, 59% were of nonWhite ethnicity, and 10% had a previous mental health problem. The index child was mean 4 years old, allergic to a mean 2.8 foods, 76% had eczema, 22% had asthma, and 31% had a history of anaphylaxis.
Baseline maternal STAI-S was mean 36.3, similar to our previous study of mothers of children with food allergy. 5 The randomized groups were similar at baseline and had a similar number of stressful life events during the 1-year follow-up (mean 1.13 intervention, 1.22
control P=.64).
| Effect of the psychological intervention on maternal anxiety, stress and risk perception
The primary outcome STAI-S did not differ between groups at 6 weeks but was significantly reduced in the intervention group at Primary outcome assessment at 6 wk 92 participants assessed 6 lost to follow up
Primary outcome assessment at 6 wk 90 participants assessed 4 lost to follow up 3 withdrew -bereavement; time pressure; no reason given Secondary outcome assessment at 1 year 80 participants assessed 9 lost to follow up 3 withdrew -bereavement; time pressure (2) Secondary outcome assessment at 1 year 85 participants assessed 4 lost to follow up 1 withdrew -time pressure 1 year, with mean difference 3.5 points (95% CI 0.3, 6.7; d=0.33) ( Table 2) . When analysed as within-group changes, we found a significant decrease in STAI-S at 6 weeks in both groups-intervention mean difference 4.4 (1.6, 7.3; P=.003; d=0.42), control mean differ- than the control group at 6 weeks, by mean 13.5-fold (mean difference on log 10 scale was À1.13 95% CI À1.77, À0.49; d=0.52) and 11.0-fold (mean difference on log 10 scale was À1.04 95% CI À1.70, À0.37; d=0.46), respectively. This difference was still present at 1 year, but at this time-point, the active intervention group also estimated all-cause fatality as less likely than the control group, and the differences in risk perception for fatal outcomes at 1 year were not significant after adjustment for false discovery.
| Effect of the psychological intervention in specific subgroups of participating mothers
We analysed the same outcomes in those participants with moderate/high STAI-S (≥35) at enrolment (Table 3) . This analysis showed a significant reduction in the primary outcome STAI-S at 6 weeks with mean difference 4.8 (0.9, 8.7; P=.016; d=0.50), but not at 1 year, and a significant reduction in STAI-T at 1 year (but not 6 weeks)-with mean difference 4.5 (0.2, 8.7; P=.038; d=0.43). Other measures of maternal anxiety, stress, quality of life or food allergy impact were not significantly different in the intervention group at either timepoint, and risk perception differed significantly at 1 year, but not at 6 weeks. The differences in STAI-T and risk perception for fatal outcomes at 1 year were not significant after adjustment for false discovery. We conducted post hoc analyses to assess whether participants who received higher quality CBT, or who showed evidence of accurately recalling the risk perception information at 6 weeks, had different outcomes to the total population. The results of these analyses are shown in the Tables S1-S3. Analysis of participants who received higher quality CBT showed no significant difference in measures of maternal anxiety, stress, quality of life or food allergy impact (Table S1) , and there was no significant relationship between CTS-R score or CBT session duration, and change in maternal anxiety or stress at 6 weeks or 1 year (Table S2 ). Analysis of participants who accurately recalled risk perception information at 6 weeks showed significantly reduced STAI-S at 1 year, but not at There was no interaction between cognitive behavioural therapy intervention and adrenaline auto-injector allocation for maternal anxiety, stress or risk perception.
T A B L E 2
Effect of the psychological intervention on maternal anxiety, stress, quality of life and risk perception Outcome measures showing significant differences are highlighted in bold. *Difference not statistically significant, after adjustment for false discovery.
6 weeks, with mean difference 5.3 (1.0, 9.4; P=.013 d=0.58) at 1 year. Maternal perceived stress was also reduced at 1 year, but not at 6 weeks, with mean difference 3.0 points (0.1, 6.0; P=.047; d=0.44; Table S3 ), although this was not significant after adjustment for false discovery.
3.3 | Effect of the psychological intervention on maternal report of child adjustment and anxiety
Maternally reported child outcomes are shown in Table S4 . Analyses were limited by small numbers available for any single outcome measure, due to heterogeneity in the instruments available for children of different ages. There was no evidence that the psychological intervention affected child adjustment at 6 weeks, or child adjustment or anxiety at 1 year.
| Effect of the psychological intervention on maternal salivary stress response
Valid salivary cortisol and a-amylase response data at more than one time-point were available from 120 participants (intervention n=56, control n=64). Summary findings are shown in Figure 2A and B, and is thought to be influenced by the evaluation of probability of a negative outcome. 19 These post hoc findings require separate confirmation, especially as the primary outcome at 6 weeks was negative.
We previously identified exaggerated risk perception in relation to childhood food allergy, in a sample of community healthcare professionals-our new findings suggest that accurate risk information at the time of first adrenaline prescription may be important for longer term maternal psychological health.
Previous work has identified increased anxiety in parents of children with food allergy, 4, 5, 20 especially mothers. 4 This is also seen in other childhood illnesses 21 and may be harmful for mother and child, especially if high level anxiety is sustained in the longterm. 22 CBT is a well-established treatment for people with anxiety disorders, 23 where it has been shown to reduced State Trait Anxiety Inventory scores, but can also be effective when used for prevention of anxiety disorders in a non-psychological setting. 24 We previously reported that CBT-competency in this setting increased with supervision over time. 10, 25 Our work provides proof of principle that paediatric staff with no prior experience of CBT can be trained to deliver CBT to mothers of children with food allergy, resulting in a significant reduction in anxiety at 1-year follow-up. A randomized controlled trial in mothers of children with other chronic illnesses suggested that peer-to-peer support programmes can also have positive effects on maternal well-being including reduced anxiety. 26 In the setting of food allergy, we are not aware of other randomized trials to address the emotional and psychological components of the condition, but observational studies suggest that passing an oral food challenge, and peer-to-peer support, may both have positive effects on maternal or child quality of life or psychological health. 27, 28 Our findings in a representative UK paediatric allergy clinic population of young children being prescribed an AAI for the first time may not be generalizable without reproducing the close CBT supervision received by allergy clinic staff in this study. Generalizability may also be influenced by intercultural variations in the psychological impact of childhood food allergy on mothers, 29 and differential effects on other caregivers such as fathers, extended family and guardians. Long-term effects on maternal psychological well-being and child adjustment, and cost-effectiveness of this intervention, remain unexplored. The decision to include all mothers, rather than just those with moderate or high baseline anxiety scores, may have reduced our ability to detect a treatment effect, due to floor effects caused by participants with low baseline anxiety. The specific timepoints for outcome evaluation in this trial relate to 6 weeks and 1 year after an allergist assessment with first AAI prescription and training.
To summarize we found that a brief CBT intervention which included a risk communication module failed to change STAI-S at 6 weeks, unless mothers already had a raised anxiety level. However, 1 year after the intervention, there was a significant reduction in maternal anxiety for all participants, supported by a reduction in stress response to a simulated anaphylaxis scenario. These findings suggest that the information given at the time of food allergy diagnosis, and any associated psychological intervention, can have significant long-term effects on maternal psychological well-being.
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